KnowTheStock
Log inCreate free account

AMGEN INC

AMGN
S&P 500Dow 30Nasdaq 100Biological Products, (No Diagnostic Substances) · Nasdaq
$423.64last close · market cap 231.31 Billion
Compare with…
63.2SCORE / 100
Our verdictHOLDStrong Growth and ImprovingQtr Ending 2026-09-30 · trend positive

Why Hold

Income statement is strong; balance sheet and cash flow are moderate.

Next earnings: 2026-11-03 (AMC), EPS Forecast: $5.74

What is strong
  • Operating Income Growth is 45.43%
  • Net Income Growth is 34.06%
  • Earnings Per Share (EPS) Growth is 33.31%
  • Net Margin is 24.14%
  • Debt Ratio is 0.27
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Revenue Growth is 8.15%
  • Current Asset to Current Liability Ratio is 1.48
  • Current Debt to Net Income Ratio is 0.62
  • Total Debt to Total Assets Ratio is 0.59
  • Cash from Operations Growth is -8.31%
  • Investment Risk is High

What changed

Score by quarter

Upgraded from Sell to Hold in the Jun 2025 quarter: 57.0 → 58.3 (+1.3). This quarter: +1.2.

40506070Mar 2023Sep 2026

What the score is made of

Income statement74.5 -0.8
Balance sheet45.5 +8.4
Cash flow56.9 -5.1

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)38.90 Billion8.15 % growth
EPS17.2533.31 % growth
Profit margin24.14 %Profit per $1 of sales
P-E ratio—Not available
Market cap231.31 BillionShares × price
Debt-equity ratio3.93Leverage
Dividend9.94Per share, annual
Next earnings2026-11-03AMC · EPS forecast $5.74
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About AMGEN INC

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.

CEO
Robert Bradway
Employees
25,200
Sector
Professional, Scientific, and Technical Services
Exchange
Nasdaq
amgen.com

Similar stocks

Loading…